Central Nervous System PRN Focus Session — Heading Off in New Directions: Review of Recent Literature and Treatment Recommendations in Migraine Management
Tuesday, October 15, 2024 from 1:15 PM to 2:45 PM MST
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-24-117-L01-P
Activity Type: An Application-Based Activity
The Central Nervous System (CNS) PRN Educational Programming Committee is offering an education session focused on the management of migraine and headaches. Specific topics will include 1) a discussion of the historical and emerging pharmacologic targets in migraine acute and prophylactic treatment, 2) a review of current guideline recommendations and evidence describing the use of traditional acute and prophylactic migraine therapies and 3) evidence-based recommendations regarding the use of novel medication therapies for acute and prophylactic migraine treatment. The target audience of this session is practicing pharmacists, pharmacy residents, pharmacy students, and associated medical professionals. The purpose of this session is to deliver education for an evolving, relevant issue to enhance pharmacist understanding and readiness in application to the clinical setting.
Faculty
![Roxana Dumitru, Pharm.D., BCCCP, BCPS Roxana Dumitru, Pharm.D., BCCCP, BCPS](/images/imis/2017079.png) | Moderator: | Roxana Dumitru, Pharm.D., BCCCP, BCPS |
|
Learning Objectives
1. Describe the proposed pathophysiologic causes of migraines.
2. Explain current research on new and emerging pharmacologic targets in migraine abortive and prophylactic therapies.
3. Analyze the current evidence-based recommendations for traditional abortive and prophylactic migraine therapies.
4. Evaluate the evidence regarding novel medication therapies for migraine abortive therapy and prophylaxis and describe their potential roles in therapy.
5. Design an evidence-based treatment regimen including abortive and prophylactic therapies for a patient living with migraines.
Priming Migraine Management: Establishing a Solid Foundation in Pathophysiology, Etiology, and Abortive Therapy1:15 PM to 1:45 PM ![Megan E. Fleischman, Pharm.D., BCACP Megan E. Fleischman, Pharm.D., BCACP](/images/imis/2031142.png) | Speaker: | Megan E. Fleischman, Pharm.D., BCACP |
|
|
Timeless Elegance: Current Migraine Prophylactic and Abortive Therapies1:45 PM to 2:15 PM ![Kayla R. Joyner, Pharm.D., BCPS Kayla R. Joyner, Pharm.D., BCPS](/images/missing_image.png) | Speaker: | Kayla R. Joyner, Pharm.D., BCPS |
|
|
Mixing the Palette: Decision-Making in Migraine Therapy2:15 PM to 2:45 PM ![Millad J. Sobhanian, Pharm.D., BCPS Millad J. Sobhanian, Pharm.D., BCPS](/images/missing_image.png) | Speaker: | Millad J. Sobhanian, Pharm.D., BCPS |
|
|